At least two COVID-19 vaccines are scoring major successes in trials. That means a vaccine might be ready by year’s end, but not in sufficient quantity to vaccinate more than 300 million Americans. Frontline health workers and national-security personnel will be top priority, but after that, who comes next? A federal committee is considering pushing...
from New York Post https://ift.tt/2ZAwgjn
0 Comments